Skip to main content
. 2018 Nov 29;7(11):e11139. doi: 10.2196/11139

Figure 6.

Figure 6

Comparison between 3 subchronic doses of methylsulfonylmethane (MSM; 1 g, 3 g, and 6 g): percentage change in visual analog scale rhinorrhea from V1 (screening) to V3 (day 14). Significance was tested using linear mixed model analysis. *P ≤.05.